CCR5 and neoplasm: Further studies demonstrated that HSPCs primed by tumor derived factors produce CCL3-4, which act via autocrine or paracrine mechanisms on CCR5 and CCR1 to promote the differentiation of tumor associated neutrophils with immunosuppressive properties (96).